Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography

Radiology

Volumn 202, Issue 2, 1997, Pages 421-429

  Helbich, Thomas H ^a,b   Becherer, Alexander ^a   Trattnig, Siegfried ^a   Leitha, Thomas ^a   Kelkar, Pramod ^a   Seifert, Michael ^a   Gnant, Michael ^a   Staudenherz, Anton ^a   Rudas, Margarete ^a   Wolf, Georg ^a   Mostbeck, Gerhard H ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast neoplasms, emission CT (ECT); Breast neoplasms, MR; Breast neoplasms, radionuclide studies; Magnetic resonance (MR), comparative studies; Radionuclide imaging, comparative studies

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER SCINTISCANNING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0031028546     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.202.2.9015068     Document Type: Article

References (37)

1. AMA Council on Scientific Affairs. Early detection of breast cancer. JAMA 1984; 252: 3008-3011.
2. Kopans DB. Priorities for improved breast cancer imaging. In: Haus AG, Yaffe MJ, eds. Syllabus: a categorical course in physics - technical aspects of breast imaging. 2nd ed. Oak Brook, Ill: Radiological Society of North America, 1993; 299-303.
3. Tohno E, Cosgrove DO, Sloane JP. Ultrasound diagnosis of breast diseases. New York, NY: Churchill Livingstone, 1994.
4. Wiener JI, Chako AC, Merten CW, Gross S, Coffrey EL, Stein HL. Breast and axillary tissue MR imaging: correlation of signal intensities and relaxation times with pathologic findings. Radiology 1986; 160:299-305.
5. Heywang SH, Wolf A, Pruss E, Hilbertz TH, Eiermann W, Permanetter W. MR imaging of the breast with Gd-DTPA: use and limitations. Radiology 1989; 171:95-103.
6. Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology 1989; 170: 681-686.
7. Stack JP, Redmond OM, Codd MB, Dervan PA, Ennis JT. Breast disease: tissue characterization with Gd-DTPA enhancement profiles. Radiology 1990; 174:491-494.
8. Gilles R, Guinebretière JM, Lucidarme O, et al. Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 1994; 191: 625-631.
9. Boetes C, Barentsz JO, Mus RD, et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced turboFLASH subtraction technique. Radiology 1994; 193:777-781.
10. Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993; 187:493-501.
11. Dao TH, Rahmouni A, Campana F, Laurent M, Asselain B, Fourquet A. Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. Radiology 1993; 187:751-755.
12. Chenevert TL, Helvie MA, Aisen AM, et al. Dynamic three-dimensional imaging with partial k-space sampling: initial application for gadolinium-enhanced rate characterization of breast lesions. Radiology 1995; 196: 135-142.
13. Gilles R, Guinebretière JM, Toussaint C, et al. Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 1994; 191:633-638.
14. Gilles R, Zafrani B, Guinebretière JM, et al. Ductal carcinoma in situ: MR imaging -histopathologic correlation. Radiology 1995; 196:415-419.
15. Fobben ES, Rubin CZ, Kalisher L, Dembner AG, Seltzer MH, Santoro EJ. Breast MR imaging with commercially available techniques: radiologic-pathologic correlation. Radiology 1995; 196:143-152.
16. Heywang-Köbrunner SH, Schlegel A, Beck R, et al. Contrast-enhanced MRI of the breast after limited surgery and radiation therapy. J Comput Assist Tomogr 1993; 17: 891-900.
17. Boetes C, Mus RDM, Holland R, et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 1995; 197:743-747.
18. Heywang-Köbrunner SH, Beck R. Contrast-enhanced MR imaging of the breast. 2nd ed. Berlin, Germany: Springer-Verlag, 1995.
19. Khalkhali I, Mena I, Jouanne E, et al. Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg 1994; 178:491-197.
20. Khalkhali I, Cutrone JA, Mena IG, et al. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 1995; 196:421-426.
21. Scopinaro F, Schillaci O, Scarpini M, et al. Technetium-99m sestamibi: an indicator of breast cancer invasiveness. Eur J Nucl Med 1994; 21:984-987.
22. Becherer A, Helbich TH, Jakesz R, Teleky B, Kubista E, Leitha T. Detection of breast cancer by scintimammography with technetium-99m-sestamibi (abstr). Eur Radiol 1995; 5:1399.
23. Svane G, Potchen EJ, Sierra A, Azavedo E. Screening mammography: breast cancer diagnosis in asymptomatic women. St Louis, Mo: Mosby-Year Book, 1993.
24. Beahrs OH, Henson DE, Hutter R, Kennedy BJ, eds. Manual for the staging of cancer. 4th ed. Philadelphia, Pa: Lippincott, 1992.
25. Rosner B. Fundamentals of biostatistics. Boston, Mass: PWS-Kent, 1990.
26. Knopp MV, Sinn P, Junkermann HJ, et al. Fibroadenomas in MR-mammography: is there a correlation between enhancement pattern and histology? (abstr). In: Proceedings of the Society of Magnetic Resonance 1995. Berkeley, Calif: Society of Magnetic Resonance, 1995; 3:1604.
27. Oellinger H, Heins S, Sander B, et al. Gd-DTPA enhanced MRI of breast: the most sensitive method for detecting multicentric carcinomas in female breast? Eur Radiol 1993; 3:223-226.
28. Heywang-Köbrunner SH, Haustein H, Pohl C, et al. Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine. Radiology 1994; 191:639-646.
29. Miller RW, Harms SE. Mucinous carcinoma of the breast: potential false-negative MR imaging interpretation (letter). AJR 1996; 167:539.
30. Dantendorfer K, Wimberger D, Katschnig H, Imhof H. Claustrophobia in MRI scanners. Lancet 1991; 338:761-762.
31. Lee VW, Sax EJ, McAneny DB, et al. A complementary role for thallium-201 scintigraphy with mammography in the diagnosis of breast cancer. J Nucl Med 1993; 12:2095-2100.
32. Waxman AD, Ramanna L, Memsic LD, et al. Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 1993; 34:18-23.
33. Chiu ML, Kronange JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis(2-methoxyisobutyl-isonitrile) technetium in cultured mouse fibroblasts. J Nucl Med 1990; 31:1646-1653.
34. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993; 53:977-984.
35. Piccolo S, Lastoria S, Mainolfi C, Muto P, Bazzicalupo L, Salvatore M. Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer. J Nucl Med 1995; 36:718-724.
36. Leitha T, Meghdadi S, Studnicka M, et al. The role of 123I-tyr 3 octreotide scintigraphy in the staging of small lung cancer. J Nucl Med 1993; 34:1397-1402.
37. Leitha T, Staudenherz A, Hermann M, Hüttinger M, Gmeiner B. Parenchymal and non-parenchymal uptake of 99mTc-, 111In-, and 125I-LDL in the normal and estradiol stimulated rat liver. Hepatology 1995; 22:1289-1295.